Silvano Coletti, PhD(c)Founder and CEO of Chelonia SA, Silvano Coletti is a serial entrepreneur and academic with extensive expertise in AI, high-performance computing (HPC), and healthcare innovation. A PhD student at Università degli Studi Guglielmo Marconi in Rome, he serves as Work Package leader in several Horizon Europe projects, driving advancements in real-time health monitoring and computational modeling. As of today he is PI at Avithrapid, a EU and Swiss backed project aiming to develop new antiviral candidates with broad spectrum leveraging on AI drug repurposing. Author of the 2023 Springer Nature book Exscalate, he has contributed to the development of one of the world’s leading AI platforms for drug repurposing and design. Formerly a fellow with Nobel Laureate Prof. Ilya Prigogine, he holds degrees in Industrial Engineering and Engineering Management, with executive training from MIT Sloan in Artificial Intelligence and Harvard Business School.